Modeling human neurodegenerative diseases in transgenic systems. - Wikidata - awgldk - TriplyDB

Modeling human neurodegenerative diseases in transgenic systems.

Modeling human neurodegenerative diseases in transgenic systems.

http://www.wikidata.org/entity/Q37968206

about

Neural stem/progenitor cells in Alzheimer's disease Regeneration, Plasticity, and Induced Molecular Programs in Adult Zebrafish Brain Disrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal models C. elegans expressing human β2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype Genetic variants associated with neurodegenerative Alzheimer disease in natural models Synaptic abnormalities in a Drosophila model of Alzheimer's disease Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model.Bovine Brain: An in vitro Translational Model in Developmental Neuroscience and Neurodegenerative Research Prion protein facilitates synaptic vesicle release by enhancing release probability.mNos2 deletion and human NOS2 replacement in Alzheimer disease models Wnt Signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice.Mechanisms, models and biomarkers in amyotrophic lateral sclerosis Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.Lessons from the analysis of nonhuman primates for understanding human aging and neurodegenerative diseases Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.Human pluripotent stem cells: applications and challenges in neurological diseases.Quantitative mouse brain phenotyping based on single and multispectral MR protocols.Models for preclinical studies in aging-related disorders: One is not for all.Thinking laterally about neurodegenerative proteinopathies.Modeling Alzheimer's disease: from past to future The Simple Chordate Ciona intestinalis Has a Reduced Complement of Genes Associated with Fanconi Anemia.Protein folding and aggregation into amyloid: the interference by natural phenolic compounds CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling.Genome resource banking of biomedically important laboratory animals.Oxidative stress in genetic mouse models of Parkinson's disease.Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation.Wisdom from the fly.From Neurodegeneration to Brain Health: An Integrated Approach.Effects of transgenic sterilization constructs and their repressor compounds on hatch, developmental rate and early survival of electroporated channel catfish embryos and fry.FTD and ALS--translating mouse studies into clinical trials.Noncoding RNAs in protein clearance pathways: implications in neurodegenerative diseases.Role of Plant Polyphenols in Alzheimer's Disease.Prion protein as a mediator of synaptic transmission Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent.Mass Histology to Quantify Neurodegeneration in Drosophila.Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease.Differential centrifugation-based biochemical fractionation of the Drosophila adult CNS.Time to recognize zebrafish ‘affective’ behavior

P2860

Q26738352-D0973A36-B169-410E-B1B1-6F0F5ED6A31E Q26784566-0BC2EB08-B622-4CE9-938E-8209B598FF67 Q26995918-3A0F65D3-5571-4408-9A1B-F85F2E5C4A0B Q27325393-C1AA93F2-99C0-4EC6-B7F9-71B282DE6FD2 Q28079843-78F23A70-3148-4067-B2A9-4D921FF32491 Q30573528-A4096D24-627D-4761-AE84-6B6AC2AC80A0 Q33659976-E5058164-46F1-4D4C-81E1-049F353C04D3 Q33876851-6256F9CA-16F9-4000-B63F-D1185BA50396 Q33991740-F60702CB-81B2-4FE6-9BC0-1B208106DB7E Q34041402-CE8F52BE-32F0-45C8-AC53-E4E00BA2A40A Q34222827-EE162196-7968-4E22-A02D-8C96DC880F72 Q34344992-14994300-7B79-4445-B86D-FC7D53C91C79 Q35085348-929D8B7B-EFEE-4200-8D6D-B1BE29EB0229 Q35145776-B8189E2C-9149-4B94-90BC-789C859741A5 Q35997893-224D42BD-B20C-4F3B-B625-252701704859 Q36193696-AA5B75D7-8B6E-43DB-A1BA-7B7A47E56635 Q36706021-59CF308E-7C2B-407A-BBC1-1CDCD1E2FFDF Q36738466-478F505F-E647-4D03-BAC1-CC8A83B46032 Q36793466-1BB5341D-522F-4C79-B90F-8EA809FE83B6 Q36938165-F3161473-6343-4E21-9817-86F64AB85BA8 Q36982306-6D8E977D-8158-4DAD-83E2-58ADBB8828CB Q37007345-1B0A722B-0E3D-4D33-B6FE-67D29C2542DC Q37559474-5936C374-B492-4B17-8CA4-F8D77C41C76A Q37612445-04580D97-8EC7-47BD-B60E-24566038B733 Q38029327-579216D9-3174-4B44-AC2F-1DAB97335870 Q38217070-CF92C0FF-5FBE-4366-A124-EF9381A9958F Q38243755-843B5C80-46BA-4F69-BD2A-71C2D61CE353 Q38365566-D5EF890E-476F-4766-82A4-B338C3516159 Q38415660-AB25FD79-2104-41EF-80F2-678FE128A6D0 Q38457811-DB81E5FB-CB2E-4FC0-9FE7-7FCE565B8286 Q38866142-FD05B1D9-5E79-4619-A0B3-68AE69A14AC6 Q39167148-9069F482-5A16-4782-9489-906D4C61654A Q41277418-E6841889-4C8D-4C2B-926B-7CE37F3D9A92 Q41523783-AC856868-4867-4915-BD60-B227B1B08DD6 Q45924774-47E83645-2CE2-490D-9FDB-55C9B4863C79 Q48369311-92CFA1A2-9B26-46DE-BCD7-DB1E769E6BAC Q51533022-E6403564-692F-4CC2-8311-BE257D3376B2 Q52782412-B9E1FBB4-6BE9-4140-94CD-0D48253F07F6 Q58012123-6327111B-292A-4838-9825-5BC2C07E4F3D

P2860

Modeling human neurodegenerative diseases in transgenic systems.

http://www.wikidata.org/entity/Q37968206

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Modeling human neurodegenerative diseases in transgenic systems.

@en

Modeling human neurodegenerative diseases in transgenic systems.

@nl

type

label

Modeling human neurodegenerative diseases in transgenic systems.

@en

Modeling human neurodegenerative diseases in transgenic systems.

@nl

prefLabel

Modeling human neurodegenerative diseases in transgenic systems.

@en

Modeling human neurodegenerative diseases in transgenic systems.

@nl

P1433

Q37968206-D0D0B6AA-1404-4EAA-B54B-AE5183543863

P1476

Q37968206-5F37F765-F3F6-4140-95E3-BBA7C8B96A4C

P2093

Q37968206-1A4707F6-ED91-4844-8374-77823421BEEC

Q37968206-BB253774-7AF7-4A5D-A700-807E84754E74

Q37968206-F498A3E5-0DCD-4E72-8EA8-F422289E7BBA

P2860

Q37968206-0097543F-1618-4CD4-A615-25F6F110101E

Q37968206-01B998D3-53BC-43F8-8EC2-61217F7D6294

Q37968206-025742BA-D7F9-4D04-AE0E-A0E4E62B736C

Q37968206-02B09332-D92B-4BD5-AB60-3BBFBF9C0CDE

Q37968206-03C355F3-49D6-42F7-AE76-7198E889EE42

Q37968206-044C2E2F-D236-414F-A997-E0CCEF40DAEB

Q37968206-046F8A40-EBCD-4563-9B8A-5B6E05AB5373

Q37968206-04E23FF8-7370-470A-95EA-AD7B87216DC3

Q37968206-0631E0A7-414E-4C9B-BBC8-375E999B82A7

Q37968206-0640E0CD-0AC0-4CB9-A4A2-F37FB82B9C28

P2888

Q37968206-1B40CDC3-914D-4756-BF66-583C97723732

P304

Q37968206-4400C66A-1CDC-4CEC-8D79-3E6C88168087

P31

Q37968206-C9BDAAA8-6D4A-4DAD-BC22-A1FDE2D92E25

P356

Q37968206-26DFA780-E279-425A-8C89-2440F3ACF29F

P433

Q37968206-FA1E84C6-0333-4105-9039-95BE12BF6949

P478

Q37968206-82E07002-5869-4005-A94B-4C749FF6376A

P577

Q37968206-A768D7D8-1FA6-420C-8016-8B10E0C69292

P5875

Q37968206-A3342EC2-7523-45B6-B0B7-9704D74CFB31

P698

Q37968206-556095A9-7849-4F49-9DDB-738487565017

P921

Q37968206-813F1A06-76D4-4D4F-B4A7-50C501FB2F0C

P356

S00439-011-1119-1

P1433

P1476

Modeling human neurodegenerative diseases in transgenic systems.

@en

P2093

Gregory A Elder

http://www.w3.org/2001/XMLSchema#string

Miguel A Gama Sosa

http://www.w3.org/2001/XMLSchema#string

Rita De Gasperi

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease

Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease

Parkinson's Disease: Genetics and Pathogenesis

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease

Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

Zinc finger-based knockout punches for zebrafish genes

Targeting DNA double-strand breaks with TAL effector nucleases

P2888

s00439-011-1119-1

P304

535-563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00439-011-1119-1

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51876492

http://www.w3.org/2001/XMLSchema#string

P698

22167414

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration